Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 319247, 10 pages
http://dx.doi.org/10.1155/2013/319247
Research Article

Active Component of Danshen (Salvia miltiorrhiza Bunge), Tanshinone I, Attenuates Lung Tumorigenesis via Inhibitions of VEGF, Cyclin A, and Cyclin B Expressions

1Department of Life Sciences, Agricultural Biotechnology Center, National Chung Hsing University, Taichung 402, Taiwan
2Department of Bioresources and Molecular Biotechnology, Da-Yeh University, Changhwa 515, Taiwan
3Department of Plant Industry, National Pingtung University of Science and Technology, Pingtung 912, Taiwan
4Department of Surgery, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin 640, Taiwan
5Taichung Hospital, Department of Health, Taichung 403, Taiwan
6Department of Surgery, Taichung Veterans General Hospital, Taichung 407, Taiwan

Received 7 September 2012; Accepted 5 March 2013

Academic Editor: Mei Tian

Copyright © 2013 Yu-Tang Tung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. C. Ko, C. H. Lee, and M. J. Chen, “Risk factors for primary lung cancer among non-smoking women in Taiwan,” International Journal of Epidemiology, vol. 26, pp. 24–31, 1997. View at Google Scholar
  2. P. Martinez-Moreno, S. Nieto-Ceron, J. Torres-Lanzas et al., “Cholinesterase activity of human lung tumours varies according to their histological classification,” Cancinogensis, vol. 27, pp. 429–436, 2005. View at Google Scholar
  3. J. D. Minna, J. A. Roth, and A. F. Gazdar, “Focus on lung cancer,” Cancer Cell, vol. 1, pp. 49–52, 2002. View at Google Scholar
  4. S. S. Lin, K. C. Lai, S. C. Hsu et al., “Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF),” Cancer Letters, vol. 285, no. 2, pp. 127–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Gasparini, “The rationale and future potential of angiogenesis inhibitors in neoplasia,” Drugs, vol. 58, no. 1, pp. 17–38, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Ferrara, “VEGF and the request for tumor angiogenesis factors,” Nature Review Cancer, vol. 2, pp. 795–803, 2002. View at Google Scholar
  7. N. Ferrara and T. Davis-Smyth, “The biology of vascular endothelial growth factor,” Endocrine Reviews, vol. 18, no. 1, pp. 4–25, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Gong, Y. Li, Y. Lu et al., “Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice,” International Journal of Cancer, vol. 129, no. 5, pp. 1042–1052, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Zhou, Z. Zuo, and M. S. S. Chow, “Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use,” Journal of Clinical Pharmacology, vol. 45, no. 12, pp. 1345–1359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Xia, J. Gu, D. M. Ansley, F. Xia, and J. Yu, “Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease,” Journal of Thoracic and Cardiovascular Surgery, vol. 126, no. 5, pp. 1404–1410, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Wang, S. L. Morris-Natschke, and K. H. Lee, “New developments in the chemistry and biology of the bioactive constituents of Tanshen,” Medicinal Research Reviews, vol. 27, no. 1, pp. 133–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. W. L. Wu, W. L. Chang, and C. F. Chen, “Cytotoxic activities of tanshinones against human carcinoma cell lines,” American Journal of Chinese Medicine, vol. 19, no. 3-4, pp. 207–216, 1991. View at Google Scholar · View at Scopus
  13. M. A. Mosaddik, “In vitro cytotoxicity of Tanshinones isolated from Salvia miltiorrhiza Bunge against P388 lymphocytic leukemia cells,” Phytomedicine, vol. 10, no. 8, pp. 682–685, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Song, S. L. Yuan, Y. M. Yang, X. J. Wang, and G. Q. Huang, “Alteration of activities of telomerase in tanshinone IIA inducing apoptosis of the leukemia cells,” Zhongguo Zhongyao Zazhi, vol. 30, no. 3, pp. 207–211, 2005. View at Google Scholar · View at Scopus
  15. H. J. Sung, S. M. Choi, Y. Yoon, and K. S. An, “Tanshinone IIA, an ingredient of Salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3,” Experimental and Molecular Medicine, vol. 31, no. 4, pp. 174–178, 1999. View at Google Scholar · View at Scopus
  16. Y. Yoon, Y. O. Kim, W. K. Jeon, H. J. Park, and H. J. Sung, “Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line,” Journal of Ethnopharmacology, vol. 68, no. 1–3, pp. 121–127, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Y. Lee, H. F. Sher, H. W. Chen et al., “Anticancer effects of tanshinone I in human non-small cell lung cancer,” Molecular Cancer Therapeutics, vol. 7, pp. 3527–3538, 2008. View at Google Scholar
  18. I. T. Nizamutdinova, G. W. Lee, J. S. Lee et al., “Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules,” Carcinogenesis, vol. 29, no. 10, pp. 1885–1892, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. J. J. W. Chen, P. L. Yao, A. Yuan et al., “Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer,” Clinical Cancer Research, vol. 9, no. 2, pp. 729–737, 2003. View at Google Scholar · View at Scopus
  21. S. M. Opal and V. A. DePalo, “Anti-inflammatory cytokines,” Chest, vol. 117, no. 4, pp. 1162–1172, 2000. View at Google Scholar · View at Scopus
  22. P. L. Yao, M. F. Tsai, Y. C. Lin et al., “Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation,” Respiratory Research, vol. 6, article 89, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Yuan, Y. N. Pan, W. W. Fu, T. Makino, and Y. Kano, “Quantitative analysis of the marker compounds in Salvia miltiorrihiza root and its phytomedicinal preparations,” Chemical and Pharmaceutical Bulletin, vol. 53, no. 5, pp. 508–514, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. J. W. Chen, Y. C. Lin, P. L. Yao et al., “Tumor-associated macrophages: the double-edged sword in cancer progression,” Journal of Clinical Oncology, vol. 23, pp. 953–964, 2005. View at Google Scholar
  25. Y. T. Tung, H. L. Chen, C. W. Lai, C. J. Shen, Y. W. Lai, and C. M. Chen, “Curcumin reduces pulmonary tumorigenesis in vascular endothelial growth factor (VEGF)-overexpressing transgenic mice,” Molecular Nutrition and Food Research, vol. 55, no. 7, pp. 1036–1043, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. C. C. Yen, C. Y. Lin, K. Y. Chong et al., “Lactoferrin as a natural regimen for selective decontamination of the digestive tract: recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonates from pathogenic challenge in the gastrointestinal tract,” Journal of Infectious Diseases, vol. 199, no. 4, pp. 590–598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. J. Chen, C. Y. Wu, C. C. Chang et al., “Nuclear Kruppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis,” Cancer Biology and Therapy, vol. 7, pp. 777–782, 2008. View at Google Scholar
  28. H. L. Chen, L. C. Wang, C. H. Chang et al., “Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71,” Vaccine, vol. 26, no. 7, pp. 891–898, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. H. L. Chen, Y. W. Lai, C. S. Chen et al., “Probiotic lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract,” BioMetals, vol. 23, no. 3, pp. 543–554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. T. C. Tsai, W. Lin, S. H. Yang et al., “Granzyme G is expressed in the two-cell stage mouse embryo and is required for the maternal-zygotic transition,” BMC Developmental Biology, vol. 10, article 88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. J. Chen, C. Y. Wu, J. L. Shen et al., “Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome,” Archives of Dermatology, vol. 144, no. 12, pp. 1571–1575, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. C. Wu, H. L. Chen, C. C. Yen et al., “Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance,” Journal of Agricultural and Food Chemistry, vol. 55, no. 12, pp. 4670–4677, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Y. Ryu, C. O. Lee, and S. U. Choi, “In vitro cytotoxicity of tanshinones from Salvia miltiorrhiza,” Planta Medica, vol. 63, no. 4, pp. 339–342, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. I. T. Nizamutdinova, G. W. Lee, and J. S. Lee, “Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules,” Carcinogenesis, vol. 29, pp. 1885–1892, 2008. View at Google Scholar
  35. L. E. Eberly, J. Ockene, R. Sherwin, L. Yang, and L. Kuller, “Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters,” International Journal of Epidemiology, vol. 32, no. 4, pp. 592–599, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. I. T. Nizamutdinova, G. W. Lee, K. H. Son et al., “Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells,” International Journal of Oncology, vol. 33, no. 3, pp. 485–491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. L. F. Shyur, S. H. Lee, S. T. Chang, C. P. Lo, Y. H. Kuo, and S. Y. Wang, “Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathways,” Phytomedicine, vol. 18, no. 1, pp. 16–24, 2010. View at Publisher · View at Google Scholar · View at Scopus